National and sub-national HIV/AIDS epidemiology, socioeconomic influences, and risk factors in Iran from 1990 to 2021, global burden of disease 2021 study
- PMID: 40594450
- PMCID: PMC12216094
- DOI: 10.1038/s41598-025-06499-4
National and sub-national HIV/AIDS epidemiology, socioeconomic influences, and risk factors in Iran from 1990 to 2021, global burden of disease 2021 study
Abstract
Human immunodeficiency virus (HIV) remains a global health challenge. Iran faces significant HIV issues with rising incidence and mortality rates. While antiretroviral therapy has improved life expectancy, projections indicate an above-average increase in the next years. We aimed to report the national and subnational burden of HIV/AIDS and risk factors in Iran from 1990 to 2021 by sex, age, and socio-demographic index (SDI). The analysis used the Global Burden of Disease 2021 data on age-standardized incidence rates, prevalence, death, and disability-adjusted life years (DALYs). The Cause of Death Ensemble Model was used to estimate HIV mortality and DisMod-MR 2.1 for non-fatal outcomes. Comparative risk assessment was conducted to evaluate the burden of HIV/AIDS attributable to risk factors such as condomless sex, drug use, and intimate partner violence. A smoothing splines model was used to determine the relationship between SDI and age-standardized DALY rates for HIV/AIDS. The counts and rates were reported with 95% uncertainty intervals. In 1990, the age-standardized incidence rate of HIV/AIDS in Iran among both sexes was 0.2 (0.1, 0.7), the prevalence rate was 1.5 (1.0, 2.5), the death rate was 0.1 (0.1, 0.1), and the DALY rate was 4.2 (4.1, 4.4) per 100,000. In 2021, age-standardized proportions per 100,000 were as follows: incidence 2.3 (1.8, 3.0), prevalence 21.6 (17.6, 26.4), death 0.6 (0.6, 0.6), and DALY 31.7 (30.8, 32.9). Males had higher age-standardized rates than females in 2021. However, females showed a higher relative increase in age-standardized rates from 1990 to 2021. In 2021, the 35-39 age group observed the highest DALY rates. Drug use was the leading risk factor 19.9 (18.7, 21.1), followed by condomless sex at 5.1 (4.5, 5.8). The age-standardized DALY rate increased with SDI up to the SDI of 0.65, after which it decreased. The most affected provinces were Kermanshah, Hormozgan, and Fars. The burden of HIV in Iran has risen significantly, with males and young adults most affected. Drug use was the leading risk factor for the infection. In the following years, interdisciplinary education, policy, and healthcare efforts are necessary to reduce the burden and incidence.
Keywords: Acquired immunodeficiency syndrome; Condomless sex; Disability-adjusted life years; Drug use; Global burden of disease; HIV infections; Iran; Risk factors.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval: The ethics committee of the Kerman University of Medical Sciences, Kerman, Iran, approved the study (ethics code: IR.KMU.REC.1403.233).
Figures







Similar articles
-
Global trends in testicular and prostate cancer among adolescents and young adult males aged 15-49 years, 1990-2021: insights from the GBD study.Sci Rep. 2025 Jul 2;15(1):23388. doi: 10.1038/s41598-025-07361-3. Sci Rep. 2025. PMID: 40603429 Free PMC article.
-
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3. Lancet Glob Health. 2025. PMID: 40580986 Free PMC article.
-
Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.Int J Surg. 2025 Mar 1;111(3):2385-2397. doi: 10.1097/JS9.0000000000002260. Int J Surg. 2025. PMID: 39869379 Free PMC article.
-
Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.Autoimmun Rev. 2023 Aug;22(8):103361. doi: 10.1016/j.autrev.2023.103361. Epub 2023 May 23. Autoimmun Rev. 2023. PMID: 37230312 Review.
-
Long-term hormone therapy for perimenopausal and postmenopausal women.Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5. Cochrane Database Syst Rev. 2017. PMID: 28093732 Free PMC article.
References
-
- Swinkels, H. M. et al. HIV and AIDS. [Updated 2024 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534860/.
-
- The Joint United Nations Program on HIV/AIDS (UNAIDS) & Global, H. I. V. & AIDS statistics — Fact sheet 2023 [Available from: https://www.unaids.org/en/resources/fact-sheet.
-
- Mody, A. et al. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet403 (10425), 471–492 (2024). - PubMed
-
- Malekmohammadi, N. et al. HIV stigma among people living with HIV in Southeast Iran. J. Kerman Univ. Med. Sci.28 (5), 427–436 (2021).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical